Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06366698
PHASE3

Intravenous Iron Versus Oral Iron for the Treatment of Iron Deficiency Anemia

Sponsor: Arrowhead Regional Medical Center

View on ClinicalTrials.gov

Summary

This study aims to assess whether administering intravenous iron early in pregnancy, compared to standard oral iron treatment, can enhance hemoglobin levels before delivery and reduce the need for blood transfusions in patients with iron deficiency anemia. Patients diagnosed with iron deficiency anemia were randomly assigned to receive either oral or intravenous iron. Before treatment initiation, patients completed a symptom questionnaire baseline hemoglobin, and ferritin levels were measured. Follow-up visits occurred four weeks later and at 24 to 28 weeks gestation, involving reassessment of symptoms, laboratory testing, and monitoring of treatment adherence. Final hemoglobin levels were determined before delivery, and data on the need for blood transfusion at delivery were recorded.

Official title: Randomized Control Trial: Intravenous Iron Versus Oral Iron for the Treatment of Iron Deficiency Anemia in Pregnancy

Key Details

Gender

FEMALE

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

900

Start Date

2023-11-21

Completion Date

2025-12-30

Last Updated

2024-04-16

Healthy Volunteers

Yes

Interventions

DRUG

Venofer 200 MG Per 10 ML Injection

200 mg IV every 2 days until the targeted dose

DRUG

Ferrous sulfate

Take 1 tablet every other day with lemon/orange juice

Locations (1)

Arrowhead Regional Medical Center

Colton, California, United States